Oncology Institute
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $100,267 | $99,901 | $98,578 | $94,666 |
Gross Profit | 14,636 | 14,366 | 13,026 | 10,480 |
EBITDA | -10,307 | -12,315 | -14,846 | -16,415 |
EBIT | -12,014 | -13,888 | -16,364 | -17,904 |
Net Income | -13,182 | -16,113 | -15,479 | -16,271 |
Net Change In Cash | 100,267 | 99,901 | 98,578 | 94,666 |
Free Cash Flow | 2,431 | 1,221 | -17,486 | -16,493 |
Cash | 49,669 | 47,402 | 36,424 | 36,055 |
Basic Shares | 75,043 | 75,524 | 74,748 | 74,234 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $393,412 | $324,239 | $252,483 | $203,003 |
Gross Profit | 393,412 | 59,573 | 52,093 | 40,848 |
EBITDA | -50,880 | -70,454 | 8,402 | -7,937 |
EBIT | -57,167 | -76,327 | 3,991 | -11,278 |
Net Income | -64,663 | -83,068 | 1,657 | -10,927 |
Net Change In Cash | 393,412 | 324,239 | 252,483 | 203,003 |
Free Cash Flow | -30,327 | -40,882 | -67,285 | -35,727 |
Cash | 49,669 | 33,488 | 14,010 | 114,299 |
Basic Shares | 75,043,678 | 73,748 | 80,605 | 66,230 |
